PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes
Clinical trial NCT06091267 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06091267
- Sponsor
- Otsuka Beijing Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2026-05-31
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.